Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Eleni Tzanikou"'
Autor:
Dimitra Stergiopoulou, Athina Markou, Areti Strati, Martha Zavridou, Eleni Tzanikou, Sophia Mastoraki, Galatea Kallergi, Vassilis Georgoulias, Evi Lianidou
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract Liquid biopsy (LB) provides a unique minimally invasive tool to follow-up cancer patients over time, to detect minimal residual disease (MRD), to study metastasis-biology and mechanisms of therapy-resistance. Molecular characterization of CT
Externí odkaz:
https://doaj.org/article/144fb851fcc643398e29bf3d322421cb
Autor:
Eleni Tzanikou, Athina Markou, Eleni Politaki, Anastasios Koutsopoulos, Amanda Psyrri, Dimitris Mavroudis, Vassilis Georgoulias, Evi Lianidou
Publikováno v:
Molecular Oncology, Vol 13, Iss 12, Pp 2515-2530 (2019)
Liquid biopsy analysis, mainly based on circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA), provides an extremely powerful tool for the molecular profiling of cancer patients in real time. In this study, we directly compared PIK3CA hots
Externí odkaz:
https://doaj.org/article/211aea30b6ba4a79bca62892cdd4c526
Autor:
Evi Lianidou, Vassilis Georgoulias, Amanda Psyrri, Alexandra Voutsina, Eleni Politaki, Maria Chimonidou, Eleni Tzanikou, Areti Strati, Sophia Mastoraki
Supplementary Figure 1A Supplementary Figure 1B Supplementary Figure 2A Supplementary Figure 2B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aac4f5877bac632e8f5bf1e396fa6151
https://doi.org/10.1158/1078-0432.22460181.v1
https://doi.org/10.1158/1078-0432.22460181.v1
Autor:
Evi Lianidou, Vassilis Georgoulias, Amanda Psyrri, Alexandra Voutsina, Eleni Politaki, Maria Chimonidou, Eleni Tzanikou, Areti Strati, Sophia Mastoraki
Purpose: Liquid biopsy provides real-time monitoring of tumor evolution and response to therapy through analysis of circulating tumor cells (CTCs) and plasma-circulating tumor DNA (ctDNA). ESR1 epigenetic silencing potentially affects response to end
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29cfba7eeafd391429bbb1b71b34f35f
https://doi.org/10.1158/1078-0432.c.6524418.v1
https://doi.org/10.1158/1078-0432.c.6524418.v1
Autor:
Evi Lianidou, Eleni Tzanikou
Publikováno v:
Critical Reviews in Clinical Laboratory Sciences. 57:54-72
Breast cancer is a highly heterogeneous and dynamic disease, exhibiting unique somatic alterations that lead to disease recurrence and resistance. Tumor biopsy and conventional imaging approaches are not able to provide sufficient information regardi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e11317e46ed676331662241a7b69d94e
https://doi.org/10.1080/10408363.2019.1670615
https://doi.org/10.1080/10408363.2019.1670615
Autor:
Dimitra Stergiopoulou, Athina Markou, Eleni Tzanikou, Ioannis Ladas, G. Mike Makrigiorgos, Vassilis Georgoulias, Evi Lianidou
Publikováno v:
Cancer Research. 82:5160-5160
Background: A considerable number of estrogen receptor-positive breast cancer (ER+ BrCa) patients develop resistance to endocrine treatment. One of the most important resistance mechanisms is the presence of ESR1 mutations. The aim of the current stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74b90524825996143a9e0710bf7d1b54
https://doi.org/10.1158/1538-7445.am2022-5160
https://doi.org/10.1158/1538-7445.am2022-5160
Autor:
Ioannis Ladas, Evi Lianidou, Dimitra Stergiopoulou, G. Mike Makrigiorgos, Vassilis Georgoulias, Eleni Tzanikou, Athina Markou
Publikováno v:
Cancers, Vol 13, Iss 556, p 556 (2021)
Cancers
Volume 13
Issue 3
Cancers
Volume 13
Issue 3
Simple Summary A considerable number of estrogen-receptor–positive (ER+) breast cancer patients develop resistance to endocrine treatment. One of the most important resistance mechanisms is the presence of ESR1 mutations. In the present study, we d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b547cf1f5762aa390a8aba09448610ac
https://www.mdpi.com/2072-6694/13/3/556
https://www.mdpi.com/2072-6694/13/3/556
Autor:
Jochen Utikal, Michael Neumaier, Verena Haselmann, Eleni Tzanikou, Angelika Duda, Athina Markou, Evi Lianidou
Publikováno v:
Clinical chemistry and laboratory medicineReferences. 58(11)
Background In metastatic melanoma, 40%–50% of patients harbor a BRAF V600E mutation and are thereby eligible to receive a combined BRAF/MEK inhibitor therapy. Compared to standard-of-care tissue-based genetic testing, analysis of circulating tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::960981c293ff304a5ab18d085b5d7cef
https://pubmed.ncbi.nlm.nih.gov/31953992
https://pubmed.ncbi.nlm.nih.gov/31953992
Autor:
Areti Strati, Evi Lianidou, Sophia Mastoraki, Evangelos Bournakis, Martha Zavridou, Eleni Tzanikou, Athina Markou
Publikováno v:
Cancers
Volume 12
Issue 5
Cancers, Vol 12, Iss 1188, p 1188 (2020)
Volume 12
Issue 5
Cancers, Vol 12, Iss 1188, p 1188 (2020)
PIM-1 is an oncogene involved in cell cycle progression, cell growth, cell survival and therapy resistance, activated in many types of cancer, and is now considered as a very promising target for cancer therapy. We report for the first time that PIM-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcff55c0d48c565d463df801cd2e2eee
https://doi.org/10.3390/cancers12051188
https://doi.org/10.3390/cancers12051188
Autor:
Amanda Psyrri, Vassilis Georgoulias, Eleni Politaki, Dimitris Mavroudis, Eleni Tzanikou, Evi Lianidou, Athina Markou, Anastasios Koutsopoulos
Publikováno v:
Molecular Oncology
Molecular Oncology, Vol 13, Iss 12, Pp 2515-2530 (2019)
Molecular Oncology, Vol 13, Iss 12, Pp 2515-2530 (2019)
Liquid biopsy analysis, mainly based on circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA), provides an extremely powerful tool for the molecular profiling of cancer patients in real time. In this study, we directly compared PIK3CA hots
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35c62739a99f81fd07c52e4da70fa829
https://pubmed.ncbi.nlm.nih.gov/31254443
https://pubmed.ncbi.nlm.nih.gov/31254443